The overall goal of this application is to define conditions that are conducive to generating transplantable, 3-D human lung. Major obstacles to lung transplantation include the paucity of donor lungs available, chronic rejection the requirement for lifelong immunosuppression and high mortality. A new source of transplantable lung tissue that will not be subject to rejection is needed. Using decellularized lung matrix (DLM) as the natural foundational scaffold, our central hypothesis is that building functional, transplantable lung requires a combination of geometry that allows for appropriate cell localization and biomimetic cues superimposed on cells as they align to drive functional integration and maturation. The PI of this application developed a """"""""decellularized, ventilated lung bioreactor"""""""" system that supports the growth of fetal lung cells and is amenable to evaluation of the potential to rebuild the lung. In addition to the use of DLM, the novelty of this proposal entails the use of autologous cells with lung recellularization potential all from the same BM source, i.e. all cells are autologous to each other and have the potential to be used in translational clinical studies. Post natal/adult human iPS cells are cells that have been reprogrammed to have characteristics of embryonic stem cells. We have evidence that DLMs can be seeded with induced pluripotent stem cells (iPS cells) that give rise to alveolar type II-like cells. We wish to evaluate the use of autologous BM-derived mesenchymal stromal cells (MSCs) and iPS-derived endothelial cells (ECs) in completing the recellularization of DLM. A team of investigators representing a convergence of the fields of bioengineering, pulmonary biology, physiology, stem cells, vascular biology and thoracic surgery has been assembled.
Our aims encompass the recellularization of DLM in a developmental stage-appropriate manner that results in correct cell patterning with tight junctional barriers, gas exchange and fluid clearance functional properties. We will take a stepwise approach to determine the contribution of matrix geometry, physiological stretch and vascularization on re-epithelialization and function of recellularized constructs using human autologous progenitors and compare to native lung. We reason that by comparing different conditions head-to-head and in combination, several fundamental """"""""rules"""""""" for bioengineering an autologous functional lung will be defined. There are 3 Specific Aims in this proposal.
In Aim 1 we will determine the contribution of matrix geometry and physiological mechanical stretch on the differentiation of human progenitor cells into pulmonary cells.
In Aim 2, we will evaluate if recellularization of DLMs is best achieved with mesenchymal induction using BM-derived MSCs.
Aim 3 will determine if prior endothelialization of the DLM vascular network potentiates subsequent epithelial progenitor cell attachment to DLM, differentiation and function. We will use BM-derived endothelial cells (ECs) infused through the vasculature access to re-endothelialize DLM. Since vessels are stabilized by pericytes that are of MSC origin, we will use human BM-derived MSCs to study if they can potentiate the attachment of ECs.

Public Health Relevance

Lung transplantation is usually the only option for patients with irreversible structural lung damage but is hindered by two major obstacles - a lack of lung organ donors and chronic rejection after transplanatation. We will focus on rebuilding 3-D human lungs using ventilated, decellularized (i.e. all cells are removed) whole pig lungs as a natural 3-D matrix framework that is very similar to human lung matrix in structure and function. We will repopulate it with human adult stem cells having the potential to grow into lung tissue and produce proteins characteristic of healthy lung cells.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1-CSR-N (M1))
Program Officer
Blaisdell, Carol J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Minnesota Twin Cities
Schools of Medicine
United States
Zip Code
Spratt, John R; Mattison, Lars M; Iaizzo, Paul A et al. (2018) Lung transplant after prolonged ex vivo lung perfusion: predictors of allograft function in swine. Transpl Int 31:1405-1417
Zaidman, Nathan A; Panoskaltsis-Mortari, Angela; O'Grady, Scott M (2017) Large-conductance Ca2+ -activated K+ channel activation by apical P2Y receptor agonists requires hydrocortisone in differentiated airway epithelium. J Physiol 595:4631-4645
Loor, Gabriel; Howard, Brian T; Spratt, John R et al. (2017) Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates. Transplantation 101:2303-2311
Boyle, William S; Senger, Kyle; Tolar, Jakub et al. (2017) Heparin Enhances Transfection in Concert with a Trehalose-Based Polycation with Challenging Cell Types. Biomacromolecules 18:56-67
Godin, Lindsay M; Sandri, Brian J; Wagner, Darcy E et al. (2016) Decreased Laminin Expression by Human Lung Epithelial Cells and Fibroblasts Cultured in Acellular Lung Scaffolds from Aged Mice. PLoS One 11:e0150966
Price, Andrew P; Godin, Lindsay M; Domek, Alex et al. (2015) Automated decellularization of intact, human-sized lungs for tissue engineering. Tissue Eng Part C Methods 21:94-103
Krishna, Venkatramana D; Roach, Erin; Zaidman, Nathan A et al. (2015) Differential Induction of Type I and Type III Interferons by Swine and Human Origin H1N1 Influenza A Viruses in Porcine Airway Epithelial Cells. PLoS One 10:e0138704
Panoskaltsis-Mortari, Angela (2015) Bioreactor Development for Lung Tissue Engineering. Curr Transplant Rep 2:90-97